Status:
ACTIVE_NOT_RECRUITING
PRehab tO PreparE Living Liver Donors for Enhanced Recovery
Lead Sponsor:
University Health Network, Toronto
Conditions:
Living Donor Liver Transplantation
Eligibility:
All Genders
Phase:
NA
Brief Summary
1. to determine if a Phase III RCT of prehab vs usual care for LLDs is feasible (including rates of recruitment, adherence, adverse events, and attrition); 2. to determine what, if any, intervention o...
Detailed Description
Living donor liver transplantation (LDLT) is an established treatment for end-stage liver disease.1 Preserving health and quality of life are priorities of care for living liver donors (LLD) as they r...
Eligibility Criteria
Inclusion
- Fluent in English for the purposes of providing informed consent, completing study-related questionnaires, and understanding intervention and other study requirements
- Have a minimum of 28 days prior to scheduled LDLT
Exclusion
- They plan to be absent for more than 2 weeks of the intervention period
- Their health status changes during the pre-LDLT procedure which results in the loss of LLD candidacy
Key Trial Info
Start Date :
May 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05431361
Start Date
May 4 2022
End Date
December 12 2024
Last Update
December 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4